butabarbital decreases results of sufentanil SL by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers might decrease sufentanil stages and efficacy, perhaps precipitating withdrawal syndrome in sufferers who've formulated physical dependence to sufentanil. Discontinuation of c